SFC

CARDIOLOGIE PEDIATRIQUE

  • Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar [JACC]
  • Transcatheter Cardiac Interventions in the Newborn: JACC Focus Seminar [JACC]

CARDIO-ONCOLOGIE

  • Cardiac computed tomography-derived myocardial tissue characterization after anthracycline treatment. ESC heart failure, 9(3), 1792–1800. [DOI]
  • Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters. ESC heart failure, 9(2), 1127–1137. [DOI]
  • Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy. Journal of nuclear cardiology, 29(2), 581–589. [DOI]

CORONAIRES ET INTERVENTIONNEL

  • Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19 [JACC]

HTA

  • Early Blood Pressure Variables Associated With Improved Outcomes in VA-ECLS: The ELSO Registry Analysis [JACC]
  • Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry [JACC]

IMAGERIE CARDIOVASCULAIRE

  • Magnetic Resonance Imaging in Pediatric Myocarditis: Trends and Associations With Cost and Outcome [JACC]
  • Improving the Characterization of Stage A and B Heart Failure by Adding Global Longitudinal Strain [JACC]

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

  • Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved [JACC]
  • Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial [JACC]
  • Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data [JACC]
  • Gliflozins in the Management of Cardiovascular Disease [NEJM]
  • Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial [AHA JOURNALS]

RISQUE CARDIOVASCULAIRE

  • Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study [HEART RHYTHM JOURNAL]
  • Complicated Carotid Artery Plaques and Risk of Recurrent Ischemic Stroke or TIA [JACC]

RYTHMOLOGIE

  • Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with coronary artery disease [HEART RHYTHM JOURNAL]
  • Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation: Nationwide Cohort Study [JACC]
  • Electrical Posterior Box Isolation in Repeat Ablation for Atrial Fibrillation: A Prospective Randomized Clinical Study [JACC]
  • Simplified Integrated Clinical and Electrocardiographic Algorithm for Differentiation of Wide QRS-Complex Tachycardia: The Basel Algorithm [JACC]
  • Predictors and outcomes of in-hospital referrals for forensic investigation after young sudden cardiac death [HEART RHYTHM JOURNAL]
  • Drug Interactions Affecting Oral Anticoagulant Use [AHA JOURNALS]

USIC

  • MIRACLE2 Score and SCAI Grade to Identify Patients With Out-of-Hospital Cardiac Arrest for Immediate Coronary Angiography [JACC]

VALVULOPATHIES

  • Sex Differences in LV Remodeling and Hemodynamics in Aortic Stenosis: Sex-Specific Criteria for Severe Stenosis? [JACC]

COVID

  • Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19 [JACC]
  • Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age [NEJM]
  • Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 [NEJM]

LA FRANCE A L’HONNEUR

  • Immediate Coronary Angiogram in Out-of-Hospital Cardiac Arrest: Looking for a Miracle [JACC]

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !